Every claim has an endpoint.
Except this one.
Autism, ADHD, and neurodevelopmental care have become one of the hardest categories for health plans, employers, TPAs, and consultants to manage, not because families are asking for too much, but because the system has no clear finish line.
BrainyAct by Kinuu is a fixed-duration, outcome-measured neurodevelopmental program that helps children and young adults build the foundational skills behind attention, regulation, coordination, communication, learning, and daily function.

The system pays for care. But rarely knows if it worked.
For most high-cost medical categories, there is a protocol, a target, and an endpoint. Surgery has discharge criteria. Cardiac rehab has a program window. Physical therapy has functional goals. Autism and ADHD care often do not. That leaves health plans, self-insured employers, TPAs, brokers, and families stuck in the same cycle: rising utilization, growing claims exposure, and no defensible outcome story.
Nobody is gaming the system. The system just has no exit.
BrainyAct creates a measurable path forward.
Pick your role to see what BrainyAct solves for you.
Bend the trend without denying care.
Your only lever should not be tighter authorization. BrainyAct gives plans a clinically credible, family-friendly alternative: a fixed-duration, outcome-measured program that can support members earlier, reduce pressure on waitlists, and create structured progress data.
50% or more savings compared to traditional therapy.
Autism therapy is one of the highest per-member costs in health plans and Medicaid, yet plans often lack insight into whether care is working. BrainyAct delivers clear ROI signals within 4 months of therapy, with defensible data behind every utilization decision.
*ROI analysis for 1,000 users. For children receiving behavioral/therapeutic interventions, total annual expenditures (insurance plus out of pocket) may range from $40k to $60k depending on intensity (www.nscl.org). Estimates based on typical Medicaid rate ranges and utilization patterns.
BrainyAct is not replacing care.
It gives the system a better starting point.
Many children are placed into years of services before foundational brain-body gaps have been addressed. BrainyAct starts earlier in the chain, and when those systems improve, learning and behavior can become easier to support.
Progress across six functional domains.
The purpose is not to generate more utilization. It is to show whether the child or young adult is building the foundational skills needed to function with more confidence, regulation, and independence.
What if the claims stopped because the kids got better?
That is the point.
BrainyAct by Kinuu helps families move forward, while giving payers, employers, TPAs, and consultants the data they need to make better decisions.
Every claim has an endpoint.
Except this one.
Autism, ADHD, and neurodevelopmental care have become one of the hardest categories for health plans, employers, TPAs, and consultants to manage, not because families are asking for too much, but because the system has no clear finish line.
BrainyAct by Kinuu is a fixed-duration, outcome-measured neurodevelopmental program that helps children and young adults build the foundational skills behind attention, regulation, coordination, communication, learning, and daily function.

The system pays for care. But rarely knows if it worked.
For most high-cost medical categories, there is a protocol, a target, and an endpoint. Surgery has discharge criteria. Cardiac rehab has a program window. Physical therapy has functional goals. Autism and ADHD care often do not. That leaves health plans, self-insured employers, TPAs, brokers, and families stuck in the same cycle: rising utilization, growing claims exposure, and no defensible outcome story.
Nobody is gaming the system. The system just has no exit.
BrainyAct creates a measurable path forward.
Pick your role to see what BrainyAct solves for you.
Bend the trend without denying care.
Your only lever should not be tighter authorization. BrainyAct gives plans a clinically credible, family-friendly alternative: a fixed-duration, outcome-measured program that can support members earlier, reduce pressure on waitlists, and create structured progress data.
50% or more savings compared to traditional therapy.
Autism therapy is one of the highest per-member costs in health plans and Medicaid, yet plans often lack insight into whether care is working. BrainyAct delivers clear ROI signals within 4 months of therapy, with defensible data behind every utilization decision.
*ROI analysis for 1,000 users. For children receiving behavioral/therapeutic interventions, total annual expenditures (insurance plus out of pocket) may range from $40k to $60k depending on intensity (www.nscl.org). Estimates based on typical Medicaid rate ranges and utilization patterns.
BrainyAct is not replacing care.
It gives the system a better starting point.
Many children are placed into years of services before foundational brain-body gaps have been addressed. BrainyAct starts earlier in the chain, and when those systems improve, learning and behavior can become easier to support.
Progress across six functional domains.
The purpose is not to generate more utilization. It is to show whether the child or young adult is building the foundational skills needed to function with more confidence, regulation, and independence.
What if the claims stopped because the kids got better?
That is the point.
BrainyAct by Kinuu helps families move forward, while giving payers, employers, TPAs, and consultants the data they need to make better decisions.